Bacalso, Princess Star .
HRN: 23-93-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
METRONIDAZOLE 500MG (TAB)
10/22/2023
10/27/2023
PO
500mg
TID X 5 More Days
Thickly MSAF
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes